Department of Dermatology Weill Medical College of Cornell University New York, New York, USA
rdgranst@med.cornell.edu
The finding that CD39 on Langerhans cells modulates inflammation and immunity in the skin might lead to new strategies to alter immune responses to benefit patients and suggests a new in vitro technique for assessing the irritant potential of topical agents. (pages 358−365)
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
